Skip to content

Clinical trials

Rheumatic Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rheumatic Diseases Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20171
20192
20211
20222
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Terminated2
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tuen Mun Hospital2
Beijing University of Chinese Medicine1
Eli Lilly and Company1
Novartis Pharmaceuticals1
RenJi Hospital1
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.1
The Children's Hospital of Zhejiang University School of Medicine1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
Yun Qian1
Yunnan University of Chinese Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rheumatic Diseases11
Arthritis4
Joint Diseases3
Musculoskeletal Diseases3
Autoimmune Diseases2
Connective Tissue Diseases2
Immune System Diseases2
Arthritis, Rheumatoid1
Carpal Tunnel Syndrome1
Dry Eye Syndromes1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.